NEW YORK (GenomeWeb) – Talis Biomedical announced today it has been awarded a five-year grant for up to $5.6 million grant from the National Institute of Allergy and Infectious Diseases. The funding will support development of a point-of-care system enabling enrichment, identification, and phenotypic antibiotic susceptibility testing of pathogens directly from whole blood.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Aug
27
Sponsored by
Qiagen

This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.

Sep
17
Sponsored by
SeraCare

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.

Sep
18
Sponsored by
Horizon Discovery

In this webinar, Kevin Balbi, head of bioinformatics at Sarah Cannon Molecular Diagnostics, will discuss the validation of targeted sequencing panels on the Ion Torrent platform using Horizon Discovery’s Tru-Q controls.